Now Reading: RPG Life Sciences carves out API business into subsidiary
-
01
RPG Life Sciences carves out API business into subsidiary
RPG Life Sciences has transferred its active pharmaceutical ingredients business to a wholly-owned subsidiary, RPG Active Pharma Limited. Khaitan & Co advised the company on the carve-out and a subsequent investment by…
The Story in Brief
RPG Life Sciences has transferred its active pharmaceutical ingredients business to a wholly-owned subsidiary, RPG Active Pharma Limited. Khaitan & Co advised the company on the carve-out and a subsequent investment by private equity firm InvAscent.
The transaction was led by managing partner Haigreve Khaitan along with partners Shishir Jose Vayttaden and Aditi Singhvi. The firm's corporate, tax, intellectual property and real estate teams also assisted, Bar & Bench reports.
The Indian Opinion
Corporate carve-outs and PE deals often get framed as signs of distress when they are routine portfolio optimisation. RPG Life Sciences is sharpening focus rather than retreating. The real test will be whether InvAscent's backing helps RPG Active Pharma scale up manufacturing and compete with larger API players. Investors should watch the subsidiary's revenue growth in the next two quarters rather than read drama into the restructuring.
Source: barandbench.com
This story was synthesised by AI from the source linked above.
